Berberine Induces p53-Dependent Apoptosis through Inhibition of DNA Methyltransferase3b in Hep3B Cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The tumor suppressor gene, p53, is inactivated in the human hepatocellular carcinoma cells line, Hep3B. Berberine has been reported to inhibit the proliferation of cancer cells. This study examined whether apoptosis was induced in berberine-treated Hep3B cells and observed the association between apoptosis and the expression of p53 and DNA methyltransferase (DNMT). The cell viability was measured using an MTT assay. Apoptosis of Hep3B was measured using annexin V flow cytometry. Berberine-treated cells were examined for their DNMT enzymatic activity, mRNA expression, and protein synthesis. The p53 levels were examined by Western blot analysis. The berberine treatment resulted in increased Hep3B cell death and apoptosis in a time- and dose-dependent manner. The DNMT3b activity, mRNA expression, and protein levels all decreased after the berberine treatment. In contrast, the p53 protein levels increased with a concomitant decrease in DNMT3b. No change in the expression of ERK was observed, but the P-ERK levels decreased in a dose dependent manner. These results indicate that a treatment of Hep3B cells with berberine can reduce the expression of DNMT3b, leading to an increase in the tumor suppressant gene p53 and an increase in cell apoptosis. This shows that berberine can effectively suppress the proliferation of liver cancer cells.
Abstract
The tumor suppressor gene, p53, is inactivated in the human hepatocellular carcinoma cells line, Hep3B. Berberine has been reported to inhibit the proliferation of cancer cells. This study examined whether apoptosis was induced in berberine-treated Hep3B cells and observed the association between apoptosis and the expression of p53 and DNA methyltransferase (DNMT). The cell viability was measured using an MTT assay. Apoptosis of Hep3B was measured using annexin V flow cytometry. Berberine-treated cells were examined for their DNMT enzymatic activity, mRNA expression, and protein synthesis. The p53 levels were examined by Western blot analysis. The berberine treatment resulted in increased Hep3B cell death and apoptosis in a time- and dose-dependent manner. The DNMT3b activity, mRNA expression, and protein levels all decreased after the berberine treatment. In contrast, the p53 protein levels increased with a concomitant decrease in DNMT3b. No change in the expression of ERK was observed, but the P-ERK levels decreased in a dose dependent manner. These results indicate that a treatment of Hep3B cells with berberine can reduce the expression of DNMT3b, leading to an increase in the tumor suppressant gene p53 and an increase in cell apoptosis. This shows that berberine can effectively suppress the proliferation of liver cancer cells.
참고문헌 (39)
- Simonetti RG, "Hepatocellular carcinoma a worldwide problem and the major risk factors", Dig Dis Sci, 36, pp.962~972 (1991)
- Stephen B Baylin, "DNA hypermethylation in tumorigenesis: epigenetics joins genetics", Trends in Genetics, 16(4), pp.168~174 (2000), Elsevier BV[DOI]
- Hye-Jung Park, "DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma", Cancer Letters, 233(2), pp.271~278 (2006), Elsevier BV[DOI]
- Bong-Kyeong Oh, "DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation", International Journal of Molecular Medicine, 20, pp.65~73 (2007), Spandidos Publications[DOI]
- Rovertson KD, "DNA methylation, methyltransferases, and cancer", Oncogene, 20, pp.3139~3155 (2001)
- T.H. Bestor, "Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain.", The EMBO Journal, 11(7), pp.2611~2617 (1992), Wiley[DOI]
- Schneider-Stock R, "Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors", IDrugs, 10, pp.557~561 (2007)
- Masaki Okano, "DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development", Cell, 99(3), pp.247~257 (1999), Elsevier BV[DOI]
- P M Vertino, "De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase", Molecular and Cellular Biology, 16(8), pp.4555~4565 (1996), American Society for Microbiology[DOI]
- Ina Rhee, "CpG methylation is maintained in human cancer cells lacking DNMT1", Nature, 404(6781), pp.1003~1007 (2000), Springer Science and Business Media LLC[DOI]
- Peri H. Tate, "Effects of DNA methylation on DNA-binding proteins and gene expression", Current Opinion in Genetics & Development, 3(2), pp.226~231 (1993), Elsevier BV[DOI]
- Y. Alan Wang, "DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression", Cancer Biology & Therapy, 4(10), pp.1138~1143 (2014), Informa UK Limited[DOI]
- María Varela, "Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics", Journal of Hepatology, 46(3), pp.474~481 (2007), Elsevier BV[DOI]
- Austin Duffy, "Developing better treatments in hepatocellular carcinoma", Expert Review of Gastroenterology & Hepatology, 4(5), pp.551~560 (2014), Informa UK Limited[DOI]
- N. Engel, "Proliferative effects of five traditional Nigerian medicinal plant extracts on human breast and bone cancer cell lines", Journal of Ethnopharmacology, 137(2), pp.1003~1010 (2011), Elsevier BV[DOI]
- Hsiao-Li Wu, "Berberine inhibits the proliferation of human uterine leiomyoma cells", Fertility and Sterility, 103(4), pp.1098~1106 (2015), Elsevier BV[DOI]
- Jianhao Xu, "Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis", BMC Cancer, 19(1), pp.589~ (2019), Springer Science and Business Media LLC[DOI]
- Pengfei Guo, "An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology", Frontiers in Pharmacology, 10, pp.857~ (2019), Frontiers Media SA[DOI]
- Sangmin Kim, "Berberine Suppresses TNF-α-induced MMP-9 and Cell Invasion through Inhibition of AP-1 Activity in MDA-MB-231 Human Breast Cancer Cells", Molecules, 13(12), pp.2975~2985 (2008), MDPI AG[DOI]
- Pei-Ling Peng, "Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2", Toxicology and Applied Pharmacology, 214(1), pp.8~15 (2006), Elsevier BV[DOI]
- Subash C. Gupta, "Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals", Cancer and Metastasis Reviews, 29(3), pp.405~434 (2010), Springer Science and Business Media LLC[DOI]
- Yanwei Qing, "Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter", Cell Biology International, 38(5), pp.563~570 (2014), Wiley[DOI]
- Zhang Y, "Berberine reverses abnormal expression of L-type pyruvate kinase by DNA demethylation and histone acetylation in the livers of the non-alcoholic fatty disease rat", Int J Clin Exp Med, 8, pp.7535~7543 (2015)
- Alain Puisieux, "Retinoblastoma and p 53 tumor suppressor genes in human hepatoma cell lines", The FASEB Journal, 7(14), pp.1407~1413 (1993), Wiley[DOI]
- Arnold J Levine, "p53, the Cellular Gatekeeper for Growth and Division", Cell, 88(3), pp.323~331 (1997), Elsevier BV[DOI]
- Huiqiang Wang, "Berberine inhibits enterovirus 71 replication by downregulating the MEK", ERK signaling pathway and autophagy, 2017, pp.14(1), ~[DOI]
- Jin-Ming Hwang, "Inhibitory effect of berberine on tert -butyl hydroperoxide-induced oxidative damage in rat liver", Archives of Toxicology, 76(11), pp.664~670 (2002), Springer Science and Business Media LLC[DOI]
- Takako Yokozawa, "Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components", Journal of Pharmacy and Pharmacology, 56(4), pp.547~556 (2004), Oxford University Press (OUP)[DOI]
- Kazunori Fukuda, "Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells", Journal of Ethnopharmacology, 66(2), pp.227~233 (1999), Elsevier BV[DOI]
- N Iizuka, "Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines", Cancer Letters, 148(1), pp.19~25 (2000), Elsevier BV[DOI]
- Ning Wang, "Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: The cellular mechanism", Journal of Cellular Biochemistry, 111(6), pp.1426~1436 (2010), Wiley[DOI]
- Yu-Jing Zhang, "High frequency of promoter hypermethylation ofRASSF1A andp16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma", Molecular Carcinogenesis, 35(2), pp.85~92 (2002), Wiley[DOI]
- Marie-Pierre Lambert, "Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake", Journal of Hepatology, 54(4), pp.705~715 (2011), Elsevier BV[DOI]
- Winnie Yeo, "High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma", Liver International, 25(2), pp.266~272 (2005), Wiley[DOI]
- Lang Hu, "Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma", Hepatology International, 4(1), pp.423~432 (2010), Springer Science and Business Media LLC[DOI]
- Qiao Liu, "Berberine Induces Senescence of Human Glioblastoma Cells by Downregulating the EGFR–MEK–ERK Signaling Pathway", Molecular Cancer Therapeutics, 14(2), pp.355~363 (2015), American Association for Cancer Research (AACR)[DOI]
- Hak-Su Kim, "Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression", Biochemical Pharmacology, 83(3), pp.385~394 (2012), Elsevier BV[DOI]
- S L Friedman, "Resistance to p53-mediated growth arrest and apoptosis in Hep 3B hepatoma cells", Oncogene, 15(1), pp.63~70 (1997), Springer Science and Business Media LLC[DOI]
- P.-O. Esteve, "Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters", Proceedings of the National Academy of Sciences, 102(4), pp.1000~1005 (2005), Proceedings of the National Academy of Sciences[DOI]